Exact Sciences
EXAS
EXAS was delisted on the 20th of March, 2026.
151 hedge funds and large institutions have $916M invested in Exact Sciences in 2014 Q1 according to their latest regulatory filings, with 32 funds opening new positions, 49 increasing their positions, 51 reducing their positions, and 12 closing their positions.
167% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 12
64% more call options, than puts
Call options by funds: $67.8M | Put options by funds: $41.3M
22% more capital invested
Capital invested by funds: $752M → $916M (+$164M)
15% more funds holding
Funds holding: 131 → 151 (+20)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 51
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Invesco
Atlanta,
Georgia
|
+$26.7M |
| 2 |
Fidelity International
Hamilton,
Bermuda
|
+$9.85M |
| 3 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$9.31M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$9.01M |
| 5 |
SI
Stephens Inc
Little Rock,
Arkansas
|
+$4.59M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
O
OrbiMed
New York
|
-$41.8M |
| 2 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
-$12.1M |
| 3 |
D.E. Shaw & Co
New York
|
-$9.51M |
| 4 |
PC
Pier Capital
Stamford,
Connecticut
|
-$6.71M |
| 5 |
MHP
Manatuck Hill Partners
Westport,
Connecticut
|
-$2.89M |
EXAS Hedge Fund Activity: Q1 2014 in Review
151 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Exact Sciences (EXAS) for Q1 2014, worth a combined $916M — up 22% from $752M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new EXAS positions and 12 closed out — a net gain of 20 holders — while 49 added to existing stakes and 51 trimmed.
The largest buyer was Invesco, adding an estimated $26.7M. The largest seller was OrbiMed, cutting an estimated $41.8M.
- 151 institutional investors held Exact Sciences (EXAS) as of Q1 2014, up from 131 in Q4 2013.
- Funds reported $916M of Exact Sciences stock for Q1 2014, up 22% quarter-over-quarter.
- 32 funds opened new Exact Sciences positions in Q1 2014 and 12 closed out, a net change of +20 holders.
- The largest Exact Sciences buyer in Q1 2014 was Invesco, an estimated $26.7M added.
- The largest Exact Sciences seller in Q1 2014 was OrbiMed, an estimated $41.8M sold.
Based on aggregated 13F filings for Q1 2014.